O
Odne
A medtech startup that develops light-active medical fillers for elegant and time saving surgeries
About Odne
Odne AG is a Swiss-US medical device company targeting the global endodontics market, which sees over 60 million root canal treatments annually. Founded in 2018 by Dr. Andreas Schmocker and Mark Bispinghoff, the company originated from a partnership between two leading Swiss research institutions, EPFL and ETH Zürich, by licensing key technology assets. Formerly known as Lumendo AG, the company rebranded to Odne in November 2023 to coincide with its strategic entry into the U.S. market. CEO and co-founder Dr. Andreas Schmocker has a background in biomechanical engineering and a PhD in applied photonics, while COO and co-founder Mark Bispinghoff holds a PhD in chemistry from ETH Zurich, specializing in photoinitiators.
Read full description
The company's business model centers on the sale of its proprietary medical devices and consumables to dental professionals, specifically endodontists and general dentists performing root canal therapies. Odne has developed a technology platform for what it terms Root Preservation Therapy (RPT), designed to improve upon the historically variable success rates of traditional root canal treatments. This platform addresses key procedural pain points, including complex cleaning and difficult filling processes. To facilitate its U.S. market launch, the company established Odne Inc. in the USA and secured $5.5 million in a Series A1 financing round in March 2024, led by Revere Partners and NV Capital.
Odne’s product suite forms a comprehensive workflow. The OdneClean device utilizes hydro-dynamic cavitation with saline, offering a different approach to cleaning and disinfecting the root canal system. For filling the canal, OdneFill is a flowable, light-curing hydrogel material. This is complemented by OdneCure, a micro-laser curing lamp with a slender optical fiber designed to navigate the narrow root canal. This integrated system is engineered to be less invasive, preserve more of the natural tooth structure, and simplify the overall procedure for clinicians. The company received FDA clearance for OdneFill and OdneCure in 2023, followed by clearance for OdneClean in 2024, paving the way for its commercial rollout.
At a glance
- Founded
- 2018
- Headquarters
- Dübendorf, Switzerland
- Sector
- Health Tech & Medtech
Latest news
Press, funding announcements and product moves mentioning Odne.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Fondation FIT
Business Angels Switzerland
ZKB - Zürcher Kantonalbank
N&V Capital
Series A5 investors entered at this stage
Dental Innovation Alliance
Revere Partners
Plug and Play
H2 Fund (Cayman)
ZEISS Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Odne on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Odne on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.